Prestige Consumer Healthcare Inc. (PBH)
NYSE · Healthcare
Prestige Consumer Healthcare Inc. Long Term Debt 2010–2026
Prestige Consumer Healthcare Inc. annual/quarterly long term debt history from 2011 to 2026. Long term debt refers to financial obligations that are due more than one year in the future.
- Prestige Consumer Healthcare Inc. long term debt for the quarter ending March 31, 2026 were 994.0M, a 0.16% increase year-over-year.
- Prestige Consumer Healthcare Inc. long term debt for 2026 were 994.0M, a 0.16% increase from 2025.
- Prestige Consumer Healthcare Inc. long term debt for 2025 were 992.4M, a 11.85% decrease from 2024.
- Prestige Consumer Healthcare Inc. long term debt for 2024 were 1.13B, a 16.35% decrease from 2023.
- Prestige Consumer Healthcare Inc. long term debt for 2023 were 1.35B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Prestige Consumer Healthcare Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2026 | $994 |
| 2025 | $992 |
| 2024 | $1,126 |
| 2023 | $1,346 |
| 2022 | $1,477 |
| 2021 | $1,480 |
| 2020 | $1,730 |
| 2019 | $1,799 |
| 2018 | $1,993 |
| 2017 | $2,194 |
| 2016 | $1,625 |
| 2015 | $1,561 |
| 2014 | $934 |
| 2013 | $971 |
| 2012 | $1,124 |
| Prestige Consumer Healthcare Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2026-03-31 | $994 |
| 2025-03-31 | $992 |
| 2024-03-31 | $1,126 |
| 2023-03-31 | $1,346 |
| 2022-03-31 | $1,477 |
| 2021-03-31 | $1,480 |
| 2020-03-31 | $1,730 |
| 2019-03-31 | $1,799 |
| 2018-03-31 | $1,993 |
| 2017-03-31 | $2,194 |
| 2016-03-31 | $1,625 |
| 2015-03-31 | $1,561 |
| 2014-03-31 | $934 |
| 2013-03-31 | $971 |
| 2012-03-31 | $1,124 |
| 2011-03-31 | $487 |
Prestige Consumer Healthcare Inc. Long Term Debt — FAQ
Prestige Consumer Healthcare Inc. (PBH) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PBH's long term debt history?
The chart and table above show Prestige Consumer Healthcare Inc.'s long term debt by year and by quarter, including the growth rate.